The federal Trial to Assess Chelation (TACT) study is once again enrolling heart attack survivors. The study’s leader, Dr. Gervasio Lamas of the Mt. Sinai Medical Center in Miami, voluntarily suspended enrollment last fall after allegations were published in Medscape critical of the consent form given to patients and of the safety of the trial.The… Continue reading Update on the NIH Chelation Trial
Tag: Pulse of Natural Health
Alternative Medicine Find Wider Acceptance by Doctors, Insurers, and Hospitals, Yet They “Lack Value”
“Alternative medicine has become mainstream,” according to Associated Press medical writer Marilynn Marchione. “Consumer spending on it in some cases rivals that of traditional healthcare.” But after stating that major hospitals and clinics increasingly offer complementary and alternative medicine (CAM) therapies, that medical schools now teach CAM, and some health insurers promote deals for policyholders… Continue reading Alternative Medicine Find Wider Acceptance by Doctors, Insurers, and Hospitals, Yet They “Lack Value”
FDA Seeks Your Suggestions for Increased Transparency
The FDA has established a Transparency Task Force, and has called for public comment. We certainly applaud this as a hopeful sign. Openness in government is imperative, and prompt disclosure to the public of government activity ensures legitimacy and accountability.
Big Pharma and the FDA: Suppress the Science, Ban the Natural Substances, Sell the Drugs!
In 2005, an up-and-coming pharmaceutical company made a big mistake: they invested millions of dollars into developing a drug only to discover that the only active ingredient of the drug, pyridoxamine, was really a common, naturally occurring substance that has been sold for decades at low cost to consumers in the form of a dietary… Continue reading Big Pharma and the FDA: Suppress the Science, Ban the Natural Substances, Sell the Drugs!
Congressional Panel Wants New Review of BPA Safety
As we have reported earlier in Pulse of Health Freedom, chemicals in the packaging, surfaces or contents of many products may cause long-term health effects, including cancers of the breast, brain and testicles; lowered sperm counts, early puberty and other reproductive system defects; diabetes; attention deficit disorder, asthma and autism. A decade ago, the government… Continue reading Congressional Panel Wants New Review of BPA Safety
In Memoriam: Dr. Abram Hoffer, Vitamin Pioneer
Dr. Abram Hoffer died this week at the age of 91. A renowned Canadian psychiatrist, Dr. Hoffer was instrumental in discovering the importance of megadoses of vitamins in the treatment of psychiatric disorders like schizophrenia and bipolar disorder, and was a pioneer in the field of orthomolecular medicine.
Will FDA Call Tomatoes a “New Drug”?
Scientists say the naturally occurring antioxidant lycopene, found in abundance in tomatoes, helps block the body from absorbing “bad” LDL cholesterol. This bad cholesterol is primarily responsible for clogging arteries.
Creating a Generation of Drugged Children
Last November, the journal Pediatrics published research that found medication use among children across the United States is dramatically increasing as more kids are being treated for diabetes, hypertension, obesity, asthma, and attention-deficit hyperactivity disorder (ADHD). Using a database of prescription claims from children with private health insurance, they were able to find prescriptions for… Continue reading Creating a Generation of Drugged Children
FDA to Receive More Money from Drug Manufacturers, But Denies “Undue Influence”
The proposed budget of the US Food and Drug Administration (FDA) is worrying the Democrats. They are concerned that FDA’s annual increases in industry user fees—$828 million from manufacturers of medical and food products, including hundreds of millions drug manufacturers pay annually to help speed the review of new medicines—might compromise the agency’s independence.
Nineteen Members of Congress Ask FDA for Official Warning About Mercury in Dental Filling Amalgams
A bipartisan letter authored by Rep. Diane Watson (D-CA) and Rep. Dan Burton (R-IN), and co-signed by congresswomen and men from twelve states, has been sent to the FDA urging them to require clear warnings about mercury toxicity to every dental patient, and to establish specific protections for children and young women.